Rocket Lab's Contract Machine Keeps Humming While Wall Street Catches Its Breath
Published on 08/04/2026 at 15:04 | Redaktion boerse-global.de
The arithmetic of Rocket Lab's recent trading looks contradictory at first glance. A stock that lost roughly a quarter of its value in a single month just posted an 8.69% single-day gain, closing at €61.30. Yet over the trailing 12 months, the shares remain up 58.81%. That disconnect suggests the July selloff was less about deteriorating fundamentals and more about a market recalibrating expectations that had simply run too hot.
A Pipeline That Won't Stop Growing
Monday's bounce had a concrete catalyst. Rocket Lab secured three additional Electron launches for Japanese Earth-imaging operator iQPS, bringing the total contracted missions for that customer to 18, with flights beginning in late 2027. This isn't a first-time relationship — Rocket Lab has served as iQPS's primary launch provider since 2023 and has already delivered seven QPS-SAR satellites to orbit. Repeat orders from a satellite operator carry real weight; they signal operational reliability where it matters most.
The iQPS expansion landed on the heels of another significant win. The US Space Force awarded Rocket Lab a $266 million contract for twelve suborbital launches, with options for six additional HASTE missions. Government work of this stripe carries lower execution risk than commercial constellation deals, and its recurring nature helps build a revenue floor — even as the timeline for the company's larger Neutron rocket continues to slip.
The Broader Pivot
The order flow is part of a larger strategic repositioning. Rocket Lab is pushing beyond its identity as a pure launch provider toward a vertically integrated space company, with the June-announced acquisition of Iridium for roughly $8 billion serving as the centerpiece. The deal would hand Rocket Lab immediate access to high-margin satellite services and recurring revenue streams — a combination of satellite manufacturing, launch capability, and in-orbit operations that analysts see as the path to positive free cash flow and profitability by 2027. The logic positions the company as a more credible challenger to SpaceX across both commercial and defense markets.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The market has taken notice. Over the past seven trading sessions, the stock has climbed 9.27%. Still, it sits 54.19% below its May record high of €133.80 — a reminder of just how far the shares have fallen from their peak.
Volatility as a Feature, Not a Bug
The bear case is straightforward and difficult to dismiss. This is a stock with an annualized 30-day volatility north of 100% — a paper that can shed a quarter of its value in a month, as it just demonstrated. The July selloff appeared to price in the well-known Neutron delays, a risk that had already been widely discussed and largely discounted. What got overlooked in the carnage was that Electron and the defense business kept compounding regardless.
The technical picture supports the case for stabilization. The stock sits just 9.05% below its 200-day moving average, while the gap to the 50-day average is a wider 25.40% — a configuration suggesting the shares are converging back toward their longer-term trend rather than breaking it. The relative strength index reads 43.5, indicating the stock isn't overbought despite the recent rally.
The Numbers That Will Settle It
Whether Monday's bounce marks a genuine turning point or a brief flicker will be decided when Rocket Lab reports second-quarter results on August 10, after the US market close. Analysts are modeling revenue of roughly $231.6 million and a loss per share of $0.0583. The pattern from the prior quarter offers some encouragement: after first-quarter results, the stock jumped 34%, powered by revenue of $200.3 million — a 63.5% year-over-year increase.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
The earnings call should clarify two critical questions. First, whether the Neutron rocket's inaugural flight remains on track for the fourth quarter of 2026. Second, whether management can sustain launch cadence with a backlog that stood above $2.2 billion at the end of the first quarter.
For investors able to stomach the swings, the current setup — well above the year's low, buttressed by expanding government and commercial contracts, yet still far from the May highs — looks less like a falling knife and more like a live opportunity. The contract machine never stalled while the stock was tumbling. The question now is whether the operating numbers can convince the market to agree.
Ad
Rocket Lab Stock: New Analysis - 4 August
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
